Ledger.Open graph →
SEC Form D · filed November 1, 2023

Aspire BioPharma, Inc

Offering
$10.0M
Sold
—
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
HUMACAO, Puerto Rico
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (10)

Ernest Scheidemann · Naples, FLExec · DirectorRodrick Prat · Wickenburg, AZDirectorKraig Higginson · Humacao, Puerto RicoExec · DirectorStephen Quesenberry · salem, UTExec · DirectorEdward Kimball · Salt Lake City, UTDirectorErnest Scheidemann · Naples, FLExec · DirectorRodrick Prat · Wickenburg, AZDirectorKraig Higginson · Orem, UTExec · DirectorStephen Quesenberry · salem, UTExec · DirectorEdward Kimball · Salt Lake City, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗